---
schema_version: "secwatch.filing_event.v1"
accession: "0001159036-25-000022"
form_type: "8-K"
ticker: "HALO"
cik: "0001159036"
company_name: "HALOZYME THERAPEUTICS, INC."
filed_at: "2025-05-02T23:59:59+00:00"
generated_at: "2026-05-22T22:06:32.453140+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Halozyme stockholders elect two Class III directors and approve say-on-pay at annual meeting

## Summary
- Jeffrey W. Henderson elected with 98,993,463 votes for, 3,298,117 against; Helen I. Torley elected with 101,477,199 for, 816,675 against.
- Say-on-pay proposal approved: 98,252,464 for, 3,966,034 against, 168,127 abstain.
- Ratification of Ernst & Young as 2025 auditor approved: 112,028,211 for, 659,976 against, 78,816 abstain.
- Meeting held May 1, 2025; 112,767,003 shares represented out of 123,533,310 outstanding.

## SEC filing metadata
- accession: 0001159036-25-000022
- form_type: 8-K
- ticker: HALO
- cik: 0001159036
- company_name: HALOZYME THERAPEUTICS, INC.
- filed_at: 2025-05-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1159036/000115903625000022/0001159036-25-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1159036/000115903625000022/halo-20250501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001159036-25-000022
- JSON: https://secwatch.observer/filing/0001159036-25-000022.json
- Plain text: https://secwatch.observer/filing/0001159036-25-000022.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.